Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Our hypothesis is that prophylactic administration of 5 days of Octreotide following EMR or ampullectomy in patients with duodenal and ampullary adenomas greater than or equal to 10mm.
Epistemonikos ID: 14f7f1e6260f57b14d17b5ae75d92fe8cdfc0af7
First added on: May 11, 2024